Unexpected sequelae of the COVID-19 pandemic: A strange case of myoclonus in the Tasmanian winter

Abstract

Peritoneal dialysis treatment generates significant amounts of waste for disposal from patients’ homes. In Australia, in the days after the onset of the COVID-19 pandemic, waste collection from homes was temporarily stopped. Our patient tried to dispose of his waste by burning the used bags and tubing, using paint thinner as an accelerant. We present a case report of the unusual neurological complication he developed.

Keywords

COVID-19 myoclonus paint thinner peritoneal dialysis

Get full access to this article

View all access options for this article.

References

Dijk

Tijssen

. Management of patients with myoclonus: available therapies and the need for an evidence-based approach. Lancet Neurol 2010; 9(10): 1028–1036.

Viaene

. Overview of the neurotoxic effects in solvent-exposed workers. Arch Public Health 2002; 60: 217–232.

Dick

. Solvent neurotoxicity. Occup Environ Med 2006; 63(3): 221–226.

Joshi

Adhikari

. An overview of common organic solvents and their toxicity. J Pharm Res Int 2019; 28(3): 1–18.

Bernardini

Scoppetta

. Exposure to solvents and tardy epilepsy: 2 clinical cases. Med Lav 1992; 83(3): 266–273.

Van Hooste

. Myoclonic seizure prior to diagnosis of chronic toxic encephalopathy: a case report. J Med Case Rep 2017; 11(1): 36.

Jacobsen

Baelum

Bonde

. Temporal epileptic seizures and occupational exposure to solvents. Occup Environ Med 1994; 51(6): 429–430.

Orti-Pareja

Jimenez-Jimenez

Miquel

, et al. Reversible myoclonus, tremor, and ataxia in a patient exposed to methyl ethyl ketone. Neurology 1996; 46(1): 272.

Sugiyama-Oishi

Arakawa

Araki

, et al. A case of chronic toluene intoxication presenting stimulus-sensitive segmental spinal myoclonus. No To Shinkei 2000; 52(5): 399–403.

10.

van Valen

Wekking

van Hout

, et al. Chronic solvent-induced encephalopathy: course and prognostic factors of neuropsychological functioning. Int Arch Occup Environ Health 2018; 91(7): 843–858.

11.

van Valen

Wekking

van der Laan

, et al. The course of chronic solvent induced encephalopathy: a systematic review. Neurotoxicology 2009; 30(6): 1172–1186.

12.

Tekesin

Erdal

Mahmutoglu

, et al. A rare condition mimicking stroke: diabetic uremic encephalopathy. Ideggyogy Sz 2018; 71(9–10): 358–360.

13.

Kojovic

Cordivari

Bhatia

. Myoclonic disorders: a practical approach for diagnosis and treatment. Ther Adv Neurol Disord 2011; 4(1): 47–62.

14.

Kaufman

Parikh

Chan

, et al. Myoclonus in renal failure: two cases of gabapentin toxicity. Epilepsy Behav Case Rep 2013; 2: 8–10.

15.

Giuliani

Peri

. Effects of hyponatremia on the brain. J Clin Med 2015; 3(4): 1163–1177.

16.

Han

Trinidad

Shi

. Hypocalcemia-induced seizure: demystifying the calcium paradox. ASN Neuro 2015. DOI: 10.1177/1759091415578050.

17.

Seliger

Gillen

Longstreth

Jr , et al. Elevated risk of stroke among patients with end-stage renal disease. Kidney Int 2003; 64(2): 603–609.

18.

Piccoli

Cupisti

Aucella

, et al. Green nephrology and eco-dialysis: a position statement by the Italian Society of Nephrology. J Nephrol 2020; 33(4): 681–698.

19.

Chen

Zhou

, et al. The carbon footprints of home and in center peritoneal dialysis in China. Int Urol Nephrol 2017; 49(2): 337–343.

20.

Barraclough

Agar

JWM

. Green nephrology. Nat Rev Nephrol 2020; 16(5): 257–268.